|
 Jothydev’s Diabetes Research Centre (JDC) is a leader in technologies in diabetes care with patients coming from all over the world for deployment of advanced insulin pumps and Artificial Pancreas.
Since the year 2004, JDC has been leading in this area and throwing light among professionals and researchers on the advancements and future of devices in diabetes. Insulin pumps, Artificial Pancras, new CGM devices, diabetes apps, glucometers connected to Diabetes Tele Management system (DTMS) etc. are a few of them. To go through the original research on technologies in diabetes please visit the following journal websites:
Kesavadev J, Jain SM, Muruganathan A, Das AK. Consensus evidence-based guidelines for use of insulin pump therapy in the management of diabetes as per Indian clinical practice. The Journal of the Association of Physicians of India. 2014 Jul;62(7 Suppl):34-41.
Read More
Kesavadev J, Vigersky R, Shin J, Pillai PBS, Shankar A, Sanal G, Krishnan G, Jothydev S. Assessing the Therapeutic Utility of Professional Continuous Glucose Monitoring in Type 2 Diabetes Across Various Therapies: A Retrospective Evaluation. Adv Ther. 2017.
Read More
Kesavadev J, Shankar A, Ashok AD, Srinivas S, Ajai NA, Sanal G, Krishnan G, Ramachandran L, Jothydev S. Our First 825 T2DM Patients on 14-Day Factory-Calibrated Glucose Monitoring System: Clinical Utility and Challenges. Journal of Diabetes Science and Technology. 2017 Jul 1:1932296817717504.
Read More
Kesavadev J, Jain SM, Muruganathan A, Das AK. Consensus evidence-based guidelines for use of insulin pump therapy in the management of diabetes as per Indian clinical practice. The Journal of the Association of Physicians of India. 2014 Jul;62(7 Suppl):34-41.
Read More
Kesavadev J, Shankar A, Pillai PB, Krishnan G, Jothydev S. Cost-effective use of telemedicine and self-monitoring of blood glucose via Diabetes Tele Management System (DTMS) to achieve target glycosylated hemoglobin values without serious symptomatic hypoglycemia in 1,000 subjects with type 2 diabetes mellitus—A retrospective study. Diabetes Technology & Therapeutics. 2012 Sep 1;14(9):772-6.
Read More
|
